rapcabtagene autoleucel (YTB323): clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
Conditions studied
0
US states with sites
7
Countries
Phase breakdown
Phase 1 2
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Multiple sclerosis | 2 |
| Progressive Multiple Sclerosis | 1 |
| Relapsing Multiple Sclerosis | 1 |
Recruiting trials involving rapcabtagene autoleucel (YTB323)
- An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis
- Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)
Common questions
How many recruiting trials involve rapcabtagene autoleucel (YTB323)?
2 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.